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Abstract 
Background: Increasing rates of prosthetic joint infection (PJI) have presented challenges for general practitioners, 
orthopedic surgeons and the health care system in the recent years. The diagnosis of PJI is complex; multiple diag‑
nostic tools are used in the attempt to correctly diagnose PJI. Evidence‑based algorithms can help to identify PJI using 
standardized diagnostic steps.
Methods: We reviewed relevant publications between 1990 and 2015 using a systematic literature search in MED‑
LINE and PUBMED. The selected search results were then classified into levels of evidence. The keywords were pros‑
thetic joint infection, biofilm, diagnosis, sonication, antibiotic treatment, implant‑associated infection, Staph. aureus, 
rifampicin, implant retention, pcr, maldi‑tof, serology, synovial fluid, c‑reactive protein level, total hip arthroplasty 
(THA), total knee arthroplasty (TKA) and combinations of these terms.
Results: From an initial 768 publications, 156 publications were stringently reviewed. Publications with class I–III 
recommendations (EAST) were considered. We developed an algorithm for the diagnostic approach to display the 
complex diagnosis of PJI in a clear and logically structured process according to ISO 5807.
Conclusions: The evidence‑based standardized algorithm combines modern clinical requirements and evidence‑
based treatment principles. The algorithm provides a detailed transparent standard operating procedure (SOP) for 
diagnosing PJI. Thus, consistently high, examiner‑independent process quality is assured to meet the demands of 
modern quality management in PJI diagnosis.
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Background
The total number of hip and knee arthroplasties per-
formed in the US is constantly increasing, with an 
expected increase in total knee arthroplasties (TKAs) of 
approximately 600% by 2030. Similarly, the number total 
hip arthroplasties (THAs) performed is estimated to tri-
ple during this period, leading to a significant increase in 
revision surgeries [1].
One major reason for revision arthroplasty is pros-
thetic joint infection (PJI). The incidence of PJI after pri-
mary surgery is 0.2–1.1%; in cases of revision surgery, it 
can reach 5% [2]. In contrast with acute PJI, low-grade 
infections are characterized by unspecific symptoms, 
such as pain and early implant loosening. Typical low-
grade infections are often a result of infection with less 
virulent bacterial strains of the dermal flora, including 
coagulase-negative Staphylococci and Propionibacterium 
acnes, often lacking severe inflammatory symptoms [3].
Although it is of fundamental importance for further 
treatment, diagnosing a low-grade PJI prior to revision 
surgery can be challenging.
In addition to clinical findings, conventional radio-
graphs, erythrocyte sedimentation rate (ESR), C-reac-
tive protein (CRP), the percutaneous aspiration of 
synovial fluid for evaluating cell counts and differentials, 
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Moreover, arthroscopically or fluoroscopically con-
trolled biopsy of periprosthetic tissue can be performed. 
Some authors suggest the use of synovial biomarkers, 
leukocyte esterase tests or radionuclide imaging to sup-
port the diagnosis of a low-grade PJI [4, 5].
All tests have a role in the workup of PJI; however, the 
diagnostic values reported in the recent literature vary 
greatly [4–6].
To safely rule out or verify the presence of PJI prior to 
arthroplasty revision surgery, a customized combination 
of different diagnostic tests must be employed for every 
single case. Although the composition of an appropri-
ate set of diagnostic tests may be self-evident for senior 
orthopedic surgeons who specialize in treating PJI, it can 
be challenging for attending orthopedic surgeons and 
general practitioners. The correct preoperative diagno-
sis is, however, of major significance because treatment 
strategies differ greatly between septic and aseptic revi-
sion surgery and have far-reaching consequences for 
the patient (20). Whereas false-positive findings lead to 
unnecessary two-stage revisions, one-stage revision sur-
gery without the essential implementation of antibiotic 
therapy can result from false-negative results, inevitably 
causing new prosthetic failure and PJI persistence [6].
We, thus, developed an evidence-based diagnostic 
algorithm with examiner-independent diagnostic reli-
ability for identifying PJI, and we prospectively observed 
its use in daily clinical routine according to the require-
ments of modern quality management in our institution.
Methods
A systematic literature search was conducted in the data-
bases of PubMed and Medline using the following search 
terms: prosthetic joint infection, implant-associated infec-
tion, biofilm, diagnosis, sonication, antibiotic treatment, 
microcalorimetry, Staph. aureus, coagulase-negative staph-
ylococci, Propionibacterium rifampicin, implant retention, 
pcr, maldi-tof, serology, synovial fluid, C-reactive protein 
level, THA, TKA leucocyte esterase test, alpha-defensin 
test. All relevant publications between January 1990 and 
January 2015 were screened according to methodologi-
cal aspects using QUADAS, STARD and PRISMA crite-
ria [7–11] and classified according to the Grade system 
(The Grading of Recommendation Assessment, Develop-
ment and Evaluation). Referring to the Grade system, the 
included studies were grouped according to the EAST 
classification, shown in Table  1 and Fig.  1, which allows 
the evaluation of medical publications, reviews and recom-
mendations in terms of their level of evidence (LoE) and 
class of recommendation (CoR) [12–21].
Table 1 EAST level of  evidence (LoE) and  class of  recom-
mendation (CoR)
LoE
 I Prospective randomized controlled trials (ORCTs)
 II Clinical studies in which the data was collected prospec‑
tively, and retrospective analyses which were based on 
clearly reliable data
Types of studies so classified: observational studies, cohort 
studies, prevalence studies and case control studies
 III Studies based on retrospectively collected data. Evidence 
used in this class indicate clinical series, database or reg‑
istry review, large series of case reviews and expert opinion
CoR
 I The recommendation is convincingly justifiable based on 
the available scientific information alone. This recommen‑
dation is usually based on Class I data; however, strong 
Class II evidence may form the basis for a level I recom‑
mendation, especially if the issue does not lead itself to 
testing in a randomized trial.
 II The recommendation is reasonably justifiable by available 
scientific evidence and strongly supported by expert 
opinion
This recommendation is usually supported by Class II data or 
a preponderance of Class II evidence
 III The recommendation is supported by available data but 
adequate scientific evidence is lacking
This recommendation is generally supported by Class III 
data. This type of recommendation is useful for educa‑
tional purposes and in guiding future clinical research
Records idenfied through 
database searching 
(n = 768)
Records aer duplicates removed 
(n = 723) 
Full-text arcles assessed 
for eligibility 
(n =  156)
Full-text arcles excluded, 
with reasons 
(n =  77)
Studies included in 
qualitave synthesis 
(n =  79)
Studies excluded aer abstract 
screening  
(n =567)
723 potenally relevant 
studies idenfied by 
primary research
Fig. 1 Flow chart of selection process
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The literature review exclusively included studies 
of adults and publications in the English or German 
language. All references from the publications used 
in this study were examined for additionally relevant 
publications.
We identified 723 studies that met our search criteria. 
To perform statistically valid analyses, we only included 
studies with a minimum of 26 patients (Fig. 1).
Furthermore, only studies that used the definition cri-
teria [22] of the Musculoskeletal Infection Society (MSIS) 
[23], Infectious Diseases Society of America (IDSA) [24] 
and International Consensus Meeting [25] (Table 2) were 
included.
A total of 79 studies were included, and the data were 
extracted from the studies. Subsequently, sensitivities, spe-
cificities, positive and negative likelihood ratios and posi-
tive and negative predictive values were calculated from the 
extracted data if they were not stated in the publication.
The evidence levels of the selected studies were taken 
into account, fulfilling the formal requirement of the 
International Organization for Standardization (ISO) 
for development of algorithms. The creation of the algo-
rithm was performed according to ISO norm 5807 Modi-
fication ITU-I, initially designed for telecommunication 
defaults, to ensure explicit decision-making criteria for a 
logical and standardized procedure. The ISO 5807 norm 
defines the use of a different symbol for the single opera-
tion to create an operation plan that has only one input 
and output [26]. An algorithm that meets the ISO 5807 
criteria is composed of process and decision symbols that 
differ from the symbols for the initial criteria and end-
points. Checklists are introduced to reduce the number 
of decision symbols. For more practical reasons, the algo-
rithm should not exceed a single page in length.
Results
The algorithm was a composition of evidence-based 
procedures developed in our clinic that fulfilled the ISO 
5807. Studies were integrated dependent of their LoE in 
a logical, structured, priority-orientated way in the algo-
rithm. Checklists are located on the left side, the vertical 
flow represents the main diagnostic criteria and treat-
ment, and the horizontal flow represents the supportive 
criteria [27] (Fig. 2). For practical reasons, the decisions 
symbol has been modified to a binary-decision hexagon.
All diagnostic aspects of the algorithm and the under-
lying literature are specified below.
Risk factors checklist
In total, 31 included studies (patients: n = 312.946; LoE 
I: n =  2, LoE II: n =  13, LoE III: n =  16) discussed the 
risk factors for a PJI (Table  3). According to a study by 
Virolainen, pain in the index joint exhibits a specificity 
of 100% in patients with PJI. Various consensus recom-
mendations and expert opinions consider a limited range 
of motion in the total joint an indicator for PJI [25]. The 
risk factors according to studies with a class of recom-
mendation of I (CoR I) are an extended operation time 
(n  =  142.120) [28–32], obesity (n  =  116,682) [33–41], 
malnutrition (n = 678) [42], diabetes (n = 72,778) [35, 39, 
40, 43], immunosuppression (n = 86,675) [32, 34, 35, 37, 
41, 44, 45], Prior infection of the joint [44], prior infec-
tion [44], early implant failure [46], early implant loos-
ening [46, 47] and superficial surgical site infections [32, 
48, 49]. Other risk factors have been associated with PJI, 
although the related studies do not provide strong evi-
dence (CoR II–III); these factors include asymptomatic 
bacteriuria [50] and tooth interventions, oral surgery and 
colonoscopies, which provide a crucial risk factor for PJI 
Table 2 Definition of prosthetic joint infection













Sinus tract o o o
Identical microorganisms isolated form 2 
or more cultures
o o o
Purulence surrounding the prosthesis o o
Inflammation in histological examination 
of prosthetic tissue
o o o
Single positive culture o o
Single positive culture with virulent 
microorganism
o
Elevated synovial fluid leukocyte count o o
Elevated synovial fluid neutrophil percentage o o
Elevated serum ESR and CRP values o o





• rr ≥ 20/min or PaCO2 
  ≤ 4.3 kPa
•  h ≥ 90/min
•  t ≤ 36° C or ≥ 38° C
•  total white blood cell count 






* ESR, CRP, LEU, CREA, UREA,










Operation < 6 h
Checklist : risk factors
• pain in the replaced joint
• implant loosening





• extended OP-time > 2.5 h
• skin disorders
• metachronous PJI
• bacteremia < 1 y
• MRSA-colonisation or
  infection














Checklist: infection indicator Positive?
Yes
• positive culture in knee and
   wbcc ≥ 1,700/µl and
   polymorph ≥ 65%
• positive culture hip and
   wbcc ≥ 4,200/µl and
   polymorph ≥ 80% 
Checklist: 
arthroscopy
• positive former culture
• antibiotics
Knee:
• wbcc ≥ 1,700/µl
• polymorph ≥ 65%
Hip:
• wbcc ≥ 4,200/µl























Fig. 2 Diagnostic algorithm
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because of relevant bacteraemia [51, 52]. Likewise, skin 
disorders in the surgical area during implantation (pso-
riasis, chronic venous stasis, skin ulcers, lymphedema) 
increase the risk of implant-associated infection [41, 53].
Sepsis checklist
As a first step, sepsis and septic shock are ruled out. Con-
cerning sepsis, we included 9 studies discussing diagnos-
tic parameters and treatment options for highly acute 
PJIs. Two LoE I studies, three LoE II studies and six LoE 
III studies were included. To identify sepsis, we used the 
diagnostic criteria published by Llewelyn and Dellinger 
(CoR III) [54–56]. Prior to the initiation of a calculated 
antibiotic therapy, a synovial aspiration (CoR III) for sub-
sequent examination of cell counts and differentials and a 
microbiologic workup to identify the causative pathogen 
should be performed [55, 57, 58]. Additionally, blood cul-
tures should be obtained (CoR I) [59, 60]. Subsequently, 
early surgical focus management can significantly reduce 
the mortality rate (CoR II) [61, 62].
Physical exam
The highest LoE (CoR III) for physical examination is 
found in a study by Teller et al. [63]. They report a sen-
sitivity of 18.95% (CI 0.05–0.4) and a specificity of 100% 
(CI 0.98–1.0) for the identification of PJI based on local 
signs of inflammation, such as warmth, effusion, redness 
and swelling of the corresponding joint [63]. For fever, 
a sensitivity of 9% (CI 95 0.03–0.21) and a specificity of 
99% (CI 95 0.98–1.00) were reported. These data contrib-
ute to a negative predictive value of 0.89 and a negative 
likelihood ratio of 0.82 (CI 0.66–0.98) for local signs of 
inflammation (Table 4). Studies with higher levels of evi-
dence for clinical signs of inflammation have not yet been 
published.
Inflammatory markers
Decision paths for the CRP and ESR were derived from 
six studies with a LoE of I, resulting in a CoR I. In this 
context, Bottner et al. showed significantly increased pre-
operative CRP and ESR levels in patients with PJI com-
pared with cases with aseptic knee and hip revisions. 
Considering a cut-off value of 1.5 mg/dl for the CRP, the 
authors reported a sensitivity of 0.95 (95% CI 0.86–1.0) 
and a specificity of 0.91 (0.84–0.99). The ESR showed a 
lower sensitivity of 0.81 (0.64–0.98) and a lower speci-
ficity of 0.89 (0.82–0.97) compared with the CRP given 
a cut-off value of 32  mm/h [64]. In their series of total 
knee arthroplasties, Valle Della et  al. reported sensitivi-
ties of 0.95 (0.89–1.0) and 0.9 (0.81–0.99) and specifici-
ties of 0.75 (0.64–0.87) and 0.66 (0.53–0.79) for the CRP 
and ESR, respectively [65]. Greidanus et  al. observed 
a lower sensitivity of 0.82 (0.71–0.95) and a higher 
specificity of 0.88 (0.76–0.9) for the ESR, with a cut-off 
value of 30 mm/h. The CRP showed a sensitivity of 0.93 
(0.86–1.0) and a specificity of 0.83 (0.76–0.9) given a cut-
off value of 1.0  mg/dl [66]. In the 1980s, Kamme et  al. 
determined the ESR and reported a sensitivity of 0.89 
(0.8–0.95) and a specificity of 0.73 (0.54–0.9) [67]. Schin-
sky et  al. showed high sensitivity [ESR: 0.96 (0.91–1.0); 
CRP: 0.95 (0.89–1.0)] and a low specificity [ESR: 0.39 
(0.31–0.47); CRP: 0.71 (0.94–1.0)] for the ESR and CRP 
Table 3 Riskfactors for prosthetic joint infections
Author Year LoE (n = x) Risk factor CoR
Huotari et al. 2007 LoE II n = 8201
Smarbrekke et al. 2004 LoE II n = 31,750
Kurtz et al. 2010 LoE II n = 69,663 Extended time CoR I
Uckay et al. 2009 LoE I n = 6001
Berbari et al. 1998 LoE II n = 26,505
Dowsey et al. 2009 LoE III n = 1214
Peersman et al. 2001 LoE III n = 6120
Lübbeke et al. 2007 LoE II n = 2495
Dowsey et al. 2008 LoE III n = 1207
Pulido et al. 2008 LoE III n = 9245 Obesity CoR I
Namba et al. 2012 LoE II n = 30,491
Namba et al. 2013 LoE II n = 56,216
Malinzak et al. 2009 LoE III n = 8494
Peel et al. 2011 LoE III n = 1200
Berbari et al. 2012 LoE III n = 678 Malnutrition CoR III
Namba et al. 2013 LoE II n = 56,216
Malinzak et al. 2009 LoE III n = 8494 Diabetes CoR I
Peersman et al. 2001 LoE III n = 6120
Mraovic et al. 2011 LoE III n = 1948
Dowsey et al. 2008 LoE III n = 1207
Peersman et al. 2001 LoE III n = 6120
Jämsen et al. 2009 LoE II n = 43,149 Immunsuppres‑
sion
CoR I
Pulido et al. 2008 LoE II n = 9245
Peel et al. 2011 LoE III n = 63
Berbari et al. 1998 LoE II n = 26,505
Bongratz et al. 2008 LoE III n = 462
Jämsen et al. 2009 LoE II n = 43,149 Prior infection CoR II
Aslam et al. 2010 LoE III n = 126
Coelho‑Prabhu 
et al.
2013 LoE III n = 678 Bacteremia CoR III
Murdoch et al. 2001 LoE III n = 80





1996 Level III n = 145
Portillo et al. 2013 LoE I n = 116 Implant loosen‑
ing
CoR I
Sousa et al. 2013 LoE III n = 2497 Bacteriuria CoR III
Berbari et al. 2010 Level III n = 678 Dental CoR III
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[68]. In contrast, Savorino et al. reported a low sensitiv-
ity [ESR: 0.6 (0.3–0.9); CRP 0.38 (0.14–0.61)] but a higher 
specificity [ESR: 0.94 (0.82–1.0); CRP: 0.7(0.42–0.98)] 
[69]. Recently, Fink et  al. calculated a sensitivity of 0.73 
(0.59–0.86) and a specificity of 0.81 (0.73–0.88) for the 
CRP in their series of total knee arthroplasties [70]. Posi-
tive and negative predictive values and positive and nega-
tive likelihoods were calculated and are shown in Table 5. 
Inflammatory markers such as IL-6, PCT and TNF-alpha 
have also been the focus of clinical trials; however, there 
is no Level I or Level II study indicating their superior 
diagnostic value [71–73].
Sinus tract
According to the criteria of the MSIS, the ISDA and the 
International Consensus Meeting, a sinus tract commu-
nicating with the prosthesis is a criterion for the presence 
of a PJI [23, 25, 74]. Two studies dealing with micro-
biological cultures of patients with a sinus tracts were 
included; however, a pathogen was not identified in all 
cases (Table 4). Bogut et al. calculated a sensitivity of 0.82 
(0.66–0.98) and a specificity of 1.0 (1.0–1.0; LoE II) [75]. 
Trampus et  al. identified a positive microbiological cul-
ture in all cases after sonication and described a sensitiv-
ity of 1.0 and a specificity of 1.0 (LoE I) [76].
Joint aspiration (knee)
For tentative PJI of the knee, five studies (5×  LoE I) 
addressing percutaneous aspiration of synovial fluid were 
included. Based on an exclusive bacteriologic culture 
analysis, Fink et  al. reported a sensitivity of 0.73 (0.59–
0.86) and a specificity of 0.95 (0.91–0.99) [70]. Della Valle 
et  al. reported a similar result for microbiological cul-
tures (sensitivity 0.8 (95% CI n.p.); specificity 0.93 (95% 
CI n.p.) [65]. Four authors examined the synovial fluid, 
considering white blood cell counts (WBC) and cell dif-
ferentiation (Neutrophil-%). Trampuz et  al. observed a 
sensitivity of 0.94 (0.86–1.0) for WBC and of 0.97 (0.91–
1.0) for Neutrophil-%, with specificities of 0.88 (0.81–
0.94) and 0.98 (0.95–1.0), respectively [77]. Della Valle 
et  al. showed comparable results: WBC sensitivity 0.91 
(0.86–0.95)/specificity 1; Neutrophil-% sensitivity 0.98 
(0.93–1.0) and specificity 0.85 (0.75–0.95). Ghanem et al. 
showed a sensitivity for WBC of 0.91 (0.86–0.95) and a 
specificity of 0.88 (0.84–0.92); for Neutrophil-%, they 
found a sensitivity of 0.95 (0.92–0.98) and a specificity of 
0.95 (0.92–0.97). Zmistowski et al. confirmed the results 
in their series, reporting a sensitivities of 0.93 (0.87–0.99) 
for WBC and Neutrophil-% and specificities of 0.94 
(0.88–0.99) and 0.83 (0.75–0.91), respectively. Positive 
and negative predictive values and positive and negative 
likelihoods were calculated for all studies and are shown 
in Table 6.
Joint aspiration (hip)
The diagnostic value of percutaneous synovial aspiration 
in total hip arthroplasties was addressed in six studies cor-
responding to a LoE of I. Four studies addressed microbi-
ological cultures, and two studies addressed the WBC and 
Neutrophil-% of the synovial aspiration (Table 7).
Mulcahy et al. reported a sensitivity of 0.69 (0.46–0.91) 
and a specificity of 0.91 (0.83–0.99) for microbiologi-
cal culture [78]. Similar results with a sensitivity of 0.44 
(0.12–0.77) and a specificity of 0.91 (0.81–1.0) were pub-
lished by Malhotra et al. [79], and Barrack et al. reported 
a sensitivity of 0.6 (0.3–0.9) and a specificity of 0.88 
(0.84–0.92) [80]. Williams et al. reported a higher sensi-
tivity of 0.8 (0.71–0.9) and a specificity of 0.94 (0.9–0.97) 
[81], while Schinsky et al. published a sensitivity of 0.84 
(0.74–0.93) and specificity of 0.93 (0.89–0.97) for cell 
count analysis and a sensitivity of 0.82 (0.72–0.92) and 
specificity 0.83 (0.77–0.89) [68]. The results confirm the 
series of Dinneen et al., who reported a sensitivity of 0.89 
(0.783–0.997) and specificity of 0.91 (0.827–0.99); for 
WBC, the values were 0.89 (0.79–0.99) and 0.86 (0.76–
0.97), respectively [82].
Other synovial fluid markers, such as synovial CRP and 
synovial IL-6, and antimicrobial peptides, such as alpha-
defensin, are undergoing clinical trials [6, 83–85]. How-
ever, there is no Level I or Level II study indicating their 
superior diagnostic value.
Synovial biopsy histological workup
Overall, seven LoE I studies including 822 patients (5× 
frozen sections/2× fixed sections) addressing synovial 
biopsy and histological workup and one LoE III study 
establishing a histopathological classification of the 
periprosthetic membrane were included (Table 8). Banit 
Table 4 Physical Exam






LR for a  
positive  
result
LR for a  
negative result
Teller et al. 2000 III III 166
 Local signs 0.18 (0.02–0.34) 1 1 0.5 (0.34–0.66) n.p. 0.82 (0.66–0.98)
 Fever 0.9 (0.03–0.21) 0.99 (0.98–1.00) 0.67 (0.13–1.2) 0.88 (0.83–0.93) 13.09 (1.42–31.88) 0.92 (0.78–1.05)
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et al. showed a sensitivity of 0.45 (0.16–0.75) and speci-
ficity of 0.92 (0.85–1.0) in their cohort. Borrego et  al. 
reported a sensitivity of 0.5 (0.15–0.85), and a specificity 
of 1.00 in their series of 83 patients with THA and a sen-
sitivity of 0.67 (0.48–0.86) and a specificity of 0.8 (0.7–
0.93) in their series of 63 patients with TKA [86].
Nunez et al. calculated a sensitivity of 0.86 (0.76–0.96) 
and a specificity of 0.87 (0.8–0.94) [87].
Banit et al. observed a sensitivity of 1.0 and a specificity 
of 0.96 (0.9–1.0) for TKA and a sensitivity of 0.45 (0.16–
0.75) and a specificity of 0.92 (0.85–1.0) for THA. Over-
all, the authors reported a sensitivity of 0.67 (0.48–0.86) 
and a specificity of 0.95 (0.91–1.0) [88]. In their series of 
105 patients with painful TKA, Valle Della et al. observed 
a sensitivity of 0.88 (0.78–0.98) and a specificity of 0.96 
(0.91–1.0). For THA, Schinsky et al. reported a sensitiv-
ity of 0.73 (0.61–0.84) and a specificity of 0.94 (0.9–0.98) 
[65, 68].
Regarding fixed sections, Fink et  al. showed a sensi-
tivity of 1.0 and a specificity of 0.98 (0.95–1.0) for TKA 
(145) and a sensitivity of 0.62 (0.48–0.76) and a specificity 
of 1.0 for THA (100) [70, 89].
Synovial biopsy microbiological workup
In their series of THAs, Fink et al. showed a sensitivity 
of 0.73 (0.6–0.86) and a specificity of 0.98 for micro-
biological culture of biopsies (0.95–1.0). The combina-
tion of histological biopsy and microbiological culture 
increased the sensitivity to 0.82 (0.71–0.93) [90]. In 
their series of TKAs, they reported a sensitivity of 0.78 
(0.65–0.9) and a specificity of 0.98 (0.95–1.0); when 
combined with histological analysis, the sensitivity 
increased to 1, with equal specificity. Regarding the 
recommended number of microbiological cultures, 
the mathematical model of Atkins et  al. was used: at 
least 5 or 6 biopsy cultures should be taken [91]. Marin 
et  al. showed a sensitivity of 0.87 (0.66–0.94) and a 
specificity of 0.67 (0.56–0.76) for one positive micro-
biological culture using that model; when three posi-
tive cultures were used, the sensitivity decreased to 
0.46 (0.32–0.61), while the specificity increased to 0.98 
(0.93–0.99) [92].
Discussion
Although the diagnosis of PJIs prior to revision surgery is 
of paramount importance for further treatment, it can be 
challenging, and a well-structured diagnostic approach is 
necessary. A PJI diagnosis results in substantial changes 
in the therapeutic procedure [3]. Thus, an evidence-based 
and priority-orientated algorithm (Fig. 2) can provide an 
incremental and easy-to-use guideline for non-specialists 
and less-experienced orthopedic surgeons.
AAOS guidelines strongly recommend determining 
the ESR and CRP [93]. According to the included studies, 
sensitivities vary from 81 to 93% for the ESR and from 73 
to 95% for the CRP [93]. In a recent meta-analysis by Ber-
bari and colleagues that included 30 studies with a total 
of 3909 patients, pooled sensitivities of 75% for the ESR 
and 88% for the CRP were reported [94]. The specifici-
ties were 70 and 74%, respectively. Despite the relatively 
high sensitivity of the CRP, its specificity remains unsat-
isfactory, confirming the observations of McArthur et al. 
who identified a considerable subset of patients with PJI 
and negative serology within their series of 414 infected 
THAs. In contrast, the AAOS guidelines recommend 
percutaneous aspiration only in case of altered ESR and 
CRP levels and thus exclude seronegative patients from 
this procedure [93]. In these cases, one-stage revision 
surgery without adequate antibiotic treatment may be 
performed, inevitably resulting in new prosthetic failure 
and PJI persistence. In our algorithm, the decision to per-
form joint aspiration is based on ESR and CRP levels and 
on the radiological findings and medical history (risk fac-
tors) of the patient.
Large multicenter LoE I studies were able to define 
some risk factors. In particular, potential intraoperative 
contamination and the immune system of the patients 
were determined to have an important role. Namba et al. 
showed in a large multicenter study that an extended 
operation time leads to an increase of PJIs. An additional 
15 min of operation time was determined to increase the 
risk by up to 9% [39]. This relationship is explained by 
increased time for potential intraoperative microbial con-
tamination. However, the increased risk of PJI in immu-
nocompromised patients, such as those with rheumatoid 
arthritis and/or diabetes, has also been proven. The most 
recent studies suggest that even asymptomatic bacteriu-
ria is an independent risk factor for PJI; the authors indi-
cated that an immunocompromised status puts patients 
at risk for colonization with Gram-negative microorgan-
isms [50]. Early implant loosening (<5 years) without evi-
dence of mechanical failure or progressive radiolucency 
adjacent to the implant must be considered a decisive 
risk factor for a low-grade PJI. As proposed by Lachie-
wicz et al., premature implant loosening and the presence 
of the previously described risk factors require further 
diagnostic procedures [47]. In this context, Portillo et al. 
were able to demonstrate a significantly longer period 
between primary implantation and diagnosed aseptic 
loosening (7.8 years) compared with septic implant loos-
ening (2 years; CoR I) [46].
Considering the aforementioned evidence-based risk 
factors in our algorithm prior to joint aspiration per-
mits a benefit-risk assessment for post-interventional 
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complications and economic issues. Although iatrogenic 
complications in the context of synovial aspiration are 
considered rare, Murray et  al. reported a complication 
rate of 5.1% (0.2–10%), including hematoma, infections 
and lesions on nerve structures after synovial aspiration 
of the hip [95]. Barrack et al. showed a 1% (0.1–2.2%) rate 
of infections after synovial aspiration of the hip [96]. This 
benefit–risk assessment is of major importance to mini-
mize the risk of infection for the patient and thus avoid 
false-positive results leading to overtreatment [97].
However, the diagnostic value of synovial aspiration 
and subsequent microbiological workup is controversial 
according to recent literature. Sensitivities vary between 
12 and 89%, with specificities between 50 and 100% for 
synovial aspiration of hip joints [68, 78, 79, 81, 82, 96, 
98, 99]. Similar results are available for TKA [65, 70, 77, 
100, 101]. However, extended synovial analysis combin-
ing microbiological culture with WBC and neutrophil-% 
is the gold standard for synovial aspiration investigation. 
The sensitivity, specificity, positive/negative predictive 
value and positive/negative likelihood ratio for the WBC 
and neutrophil-% are given in Tables 6 and 7. Several stud-
ies have examined the optimal cut-off values for WBC and 
neutrophil-%. Trampuz et al. suggest 1.7 × 103/µl (WBC) 
and 65% (neutrophil-%), and Zmistowski et  al. and Della 
Valle report quite similar results, using higher cut-off val-
ues of 3.0 × 103 for WBC and 75% neutrophils [65, 101]. 
However, cut-off values calculated using receiver-operat-
ing characteristics are linked to the microbiological strains 
that cause the PJI. In our algorithm, we used the lower 
cut-off values that Trampuz et al. and Schinsky et al. iden-
tified to ensure that we detected the low-grade infections 
caused by slow-growing and low virulence strains, such as 
coagulase-negative staphylococci or Proprionibacterium 
acnes, which generate a low immune reaction. Considering 
the defining criteria for PJI (Table 2), 2 or more separate 
synovial fluid samples should be obtained from the index 
joint. However, this main criterion is usually not met with 
routine synovial aspiration. In the daily clinical routine, 
the additional use of blood culture bottles, as proposed by 
Minassian et al. [102], to obtain two separate microbiologi-
cal cultures should thus be encouraged. Although the data 
on diagnostic value are discordant, the causative patho-
gen and its antibiotic sensitivity pattern can be identified 
via synovial aspiration and microbiological examination. 
This information, in turn, is of great importance for preop-
eratively planning the surgical strategy and the antibiotic 
regimen.
Unfortunately, a causative pathogen can only be iden-
tified in approximately 44% [79]–80% [81] of cases, 
reflecting the heterogeneous diagnostic value of syno-
vial aspiration. Among the factors influencing micro-
biological results, the length of the incubation period is 
crucial because the bacteria that cause PJIs occur only in 
a very low number in the biofilm and often are in a ses-
sile form that is very slow growing [103, 104]. Accord-
ingly, in many of the aforementioned studies, the length 
of microbiological incubation was only 48  h or was not 
specifically disclosed. Furthermore, the omission of anti-
biotic treatment termination at least 2 weeks prior to the 
joint aspiration can lead to false-negative microbiological 
results and thus to maltreatment [105].
Other synovial fluid markers, such as alpha-defensin, 
show promising results, with a sensitivity of 100% [4, 
85], but they lack the evidence and independent studies 
to support their use. Similarly, the leukocyte esterase test 
requires further evidence to support its role in diagnos-
ing PJI [5, 106]. According to the Plan-Do-Check-Act 
principle, constant improvement of the algorithm by 
reintegrating actual evidence-based literature at half-year 
intervals is intended. If new diagnostic procedures fulfill 
the LoR I criteria, they will be included in the algorithm.
As a further, more invasive diagnostic step, arthro-
scopic synovial biopsy has been implemented in our 
algorithm. As itemized in the “Arthroscopy” checkbox 
(Fig.  2), increased WBC or neutrophil percentage but 
negative microbiological assessment of the aspirate, con-
tinued antibiotic treatment and history of PJI are indica-
tions for synovial biopsy according to our algorithm.
In this context, recent studies by Williams et al. showed 
equal results for aspiration and tissue biopsy with sole 
microbiological examination [81]. These results underline 
the importance of concurrent histological and microbio-
logical workup of the biopsy specimens, as confirmed by 
Malhotra and Morgan in their series of 41 THAs [79]. The 
authors reported a sensitivity of 80% and a specificity of 
100% for synovial biopsy compared with a sensitivity of 
44% and a specificity of 91% for synovial fluid aspiration. 
Likewise, Fink et al. reported synovial biopsy sensitivities 
of 100 and 87% for TKA and THA, respectively [70, 89] 
Specificity was 98% for both TKA and THA. According to 
the authors, the underlying hypothesis for the discrepancy 
of results between hip and knee joints was that biopsy 
samples can be obtained at many more places adjacent 
to the prosthesis in the knee compared with hip joints, 
where only the head and neck of the prosthesis and the 
inlay of the acetabular cup are easily accessible [89].
Despite its excellent diagnostic value, synovial biopsy 
should only be applied in selected cases, as stated above. 
Although the procedure can be considered a minor 
operation, potential risks such as neuro-vascular injury 
or surgical site infection should not be underestimated 
[107]. Furthermore, arthroscopic instruments can dam-
age the hip or knee replacement, particularly in ceramic 
implants. Thus, similar to percutaneous joint aspira-
tion, a benefit–risk assessment prior to the intervention 
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is essential to maximize the diagnostic yield within the 
diagnostic cascade and while minimizing the potentially 
harmful effects for the patient.
Conclusions
The diagnostic algorithm presented in this study is 
derived from high-quality studies in the field of PJI and 
provides a well-structured diagnostic approach in form 
of a detailed and transparent SOP. These incremental and 
easy-to-use guidelines facilitate consistently high and 
examiner-independent process quality in terms of PJI 
treatment and provide a basis for scientific analyses.
Abbreviations
PJI: prosthetic joint infection; THA: total hip arthroplasty; TKA: total knee 
arthroplasty; EAST: Eastern Association of the Surgery of Trauma; SOP: standard 
operating procedure; ESR: erythrocyte sedimentation rate; CRP: c‑reactive 
protein; GRADE: The Grading of Recommendation Assessment, Development 
and Evalutation; STARD: Standards for Reporting of Diagnostic Accuracy; LoE: 
level of evidence; CoR: class of recommendation; IDSA: Infectious Deceases 
Society of America; MSIS: Musculoskeletal Infection Society; ISO: International 
Organization for Standardization; IL‑6: interleukin‑6; PCT: procalcitonin; AAOS: 
American Academy of Orthopaedic Surgeons.
Authors’ contributions
Conception and designs: HM, FP, JS,RvER, KGK, UL. Generation, collection 
assembly, analysis and interpretation: HM, FP, KGK, UL, FL, AT, SK, NH. Drafting 
and revising the manuscript: HM, FP, KGK, JS. Approval of the final version of 
the manuscript: HM, FP, RvER, JS, KGK. All authors read and approved the final 
manuscript.
Author details
1 Department of Orthopaedic Surgery, Klinikum rechts der Isar, Technische 
Universität München, Ismaninger Str. 22, 81675 Munich, Germany. 2 Depart‑
ment of Trauma Surgery, Klinikum rechts der Isar, Technische Universität 




All authors declare that they have no competing interests.
Availability of data and materials
All data are available in the included figures, tables and bibliography.
Ethics approval and consent to participate
No approval by an institutional review board and no consent to participate 
were required.
Funding
The present study was funded by the authors institution.
Received: 1 September 2016   Accepted: 24 February 2017
References
 1. Kurtz S. Projections of primary and revision hip and knee arthro‑
plasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 
2007;89:780.
 2. Urquhart DM, Hanna FS, Brennan SL, Wluka AE, Leder K, Cameron PA, 
et al. Incidence and risk factors for deep surgical site infection after pri‑
mary total hip arthroplasty: a systematic review. J Arthroplasty Elsevier. 
2010;25:1216–22.
 3. Zimmerli W, Trampuz A. Prosthetic‑joint infections. N Engl J Med. 
2004;351:1645–54.
 4. Deirmengian C, Kardos K, Kilmartin P, Cameron A, Schiller K, Parvizi J. 
Diagnosing periprosthetic joint infection: has the era of the biomarker 
arrived? Clin Orthop Relat Res. 2014;472:3254–62.
 5. Wetters NG, Berend KR, Lombardi AV, Morris MJ, Tucker TL, Della Valle CJ. 
Leukocyte esterase reagent strips for the rapid diagnosis of peripros‑
thetic joint infection. J Arthroplast. 2012;27(8):8–11 (Elsevier Inc).
 6. Gollwitzer H, Dombrowski Y, Prodinger PM, Peric M, Summer B, Hap‑
felmeier A, et al. Antimicrobial peptides and proinflammatory cytokines 
in periprosthetic joint infection. J Bone Joint Surg Am. 2013;95:644.
 7. Whiting P, Rutjes AWS, Reitsma JB, Bossuyt PMM, Kleijnen J. The 
development of QUADAS: a tool for the quality assessment of studies 
of diagnostic accuracy included in systematic reviews. BMC Med Res 
Methodol. 2003;3:25 (BioMed Central Ltd).
 8. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, 
et al. The STARD statement for reporting studies of diagnostic accuracy: 
explanation and elaboration. Clin Chem. 2003;49:7–18.
 9. Bossuyt PM, Reitsma JB, Bruns DE. Towards complete and accurate 
reporting of studies of diagnostic accuracy: the STARD initiative. Clin 
Chem Lab Med. 2003;41:68–73.
 10. Cook DJ, Mulrow CD, Haynes RB. Systematic reviews: synthesis of best 
evidence for clinical decisions. Ann Intern Med. 1997;126:376–80.
 11. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred 
reporting items for systematic reviews and meta‑analyses: the PRISMA 
statement. PLoS Med. 2009;6:e1000097.
 12. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE 
guidelines: 1. Introduction‑GRADE evidence profiles and summary of 
findings tables. J Clin Epidemiol. 2011;64:383–94 (Elsevier Inc).
 13. Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, et al. GRADE 
guidelines: 2. Framing the question and deciding on important out‑
comes. J Clin Epidemiol. 2011;64:395–400 (Elsevier Inc).
 14. Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso‑Coello P, et al. 
GRADE guidelines: 4. Rating the quality of evidence‑study limitations 
(risk of bias). J Clin Epidemiol. 2011;64:407–15 (Elsevier Inc).
 15. Guyatt GH, Oxman AD, Montori V, Vist G, Kunz R, Brozek J, et al. GRADE 
guidelines: 5. Rating the quality of evidence‑publication bias. J Clin 
Epidemiol. 2011;64:1277–82 (Elsevier Inc).
 16. Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso‑Coello P, Rind D, et al. 
GRADE guidelines 6. Rating the quality of evidence‑imprecision. J Clin 
Epidemiol. 2011;64:1283–93 (Elsevier Inc).
 17. Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. 
GRADE guidelines: 8. Rating the quality of evidence‑indirectness. J Clin 
Epidemiol. 2011;64:1303–10 (Elsevier Inc).
 18. Dellinger EP, Gross PA, Barrett TL, Krause PJ, Martone WJ, McGowan 
JE, et al. Quality standard for antimicrobial prophylaxis in surgical 
procedures. Infectious diseases Society of America. Clin Infect Dis. 
1994;18:422–7.
 19. Guyatt GH, Oxman AD, Sultan S, Glasziou P, Akl EA, Alonso‑Coello P, 
et al. GRADE guidelines: 9. Rating up the quality of evidence. J Clin 
Epidemiol. 2011;64:1311–6 (Elsevier Inc).
 20. Guyatt GH, Oxman AD, Schünemann HJ, Tugwell P, Knottnerus A. 
GRADE guidelines: a new series of articles in the journal of clinical 
epidemiology. J Clin Epidemiol. 2011;64:380–2.
 21. Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, 
et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epide‑
miol. 2011;64:401–6 (Elsevier Inc).
 22. Oussedik S, Gould K, Stockley I. Defining peri‑prosthetic infection. J 
Bone Joint Surg Br. 2012;94:1455–6.
 23. Society TWCBTMI. New definition for periprosthetic joint infection. J 
Arthroplast. 2011;26:1136–8 (Elsevier Inc).
 24. Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, 
et al. Diagnosis and management of prosthetic joint infection: clinical 
practice guidelines by the Infectious Diseases Society of America. Clin 
Infect Dis. Oxford University Press; 2013. pp. e1–e25.
 25. Parvizi J, Gehrke T, Chen AF. Proceedings of the international consensus 
on periprosthetic joint infection. Bone Joint J. 2013;95:1450–2.
 26. ISO G. International Organisation for Standarisation (1985) ISO 5807. 
1985 Aug.
 27. Khalil PN, Kleespies A, Angele MK, Thasler WE, Siebeck M, Bruns CJ, 
et al. The formal requirements of algorithms and their implications in 
Page 14 of 15Mühlhofer et al. Eur J Med Res  (2017) 22:8 
clinical medicine and quality management. Langenbecks Arch Surg. 
2010;396:31–40.
 28. Huotari K, Lyytikäinen O, Seitsalo S. Patient outcomes after simultane‑
ous bilateral total hip and knee joint replacements. J Hosp Infect. 
2007;65:219–25.
 29. Småbrekke A, Espehaug B, Havelin LI, Furnes O. Operating time and 
survival of primary total hip replacements: an analysis of 31,745 primary 
cemented and uncemented total hip replacements from local hospitals 
reported to the Norwegian Arthroplasty Register 1987–2001. Acta 
Orthop Scand. 2004;75:524–32.
 30. Kurtz SM, Ong KL, Lau E, Bozic KJ, Berry D, Parvizi J. Prosthetic joint 
infection risk after TKA in the medicare population. Clin Orthop Relat 
Res. 2009;468:52–6 (Springer-Verlag).
 31. Uçkay I, Lübbeke A, Emonet S, Tovmirzaeva L, Stern R, Ferry T, et al. Low 
incidence of haematogenous seeding to total hip and knee prostheses in 
patients with remote infections. J Infect. 2009;59:337–45 (Elsevier Ltd).
 32. Berbari EF, Hanssen AD, Duffy MC, Steckelberg JM, Ilstrup DM, Harmsen 
WS, et al. Risk factors for prosthetic joint infection: case‑control study. 
Clin Infect Dis. 1998;27:1247–54.
 33. Dowsey MM, Choong PFM. Obese diabetic patients are at substan‑
tial risk for deep infection after primary TKA. Clin Orthop Relat Res. 
2008;467:1577–81.
 34. Dowsey MM, Choong PFM. Obesity is a major risk factor for pros‑
thetic infection after primary hip arthroplasty. Clin Orthop Relat Res. 
2008;466:153–8.
 35. Peersman G, Laskin R, Davis J, Peterson M. Infection in total knee 
replacement: a retrospective review of 6489 total knee replacements. 
Clin Orthop Relat Res. 2001;392:15–23.
 36. Lübbeke A, Stern R, Garavaglia G, Zurcher L, Hoffmeyer P. Differences 
in outcomes of obese women and men undergoing primary total hip 
arthroplasty. Arthritis Rheum. 2007;57:327–34.
 37. Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J. Periprosthetic joint infec‑
tion: the incidence, timing, and predisposing factors. Clin Orthop Relat 
Res. 2008;466:1710–5.
 38. Namba RS, Inacio M, Paxton EW. Risk factors associated with surgical 
site infection in 30,491 primary total hip replacements. J Bone Joint 
Surg Br. 2012;94:1330–8.
 39. Namba RS, Inacio MCS, Paxton EW. risk factors associated with deep 
surgical site infections after primary total knee arthroplasty. J Bone Joint 
Surg Am. 2013;95:775–8.
 40. Malinzak RA, Ritter MA, Berend ME, Meding JB, Olberding EM, Davis 
KE. Morbidly obese, diabetic, younger, and unilateral joint arthroplasty 
patients have elevated total joint arthroplasty infection rates. J Arthro‑
plast. 2009;24(6):84–8.
 41. Peel TN, Dowsey MM, Daffy JR, Stanley PA, Choong PFM, Buising KL. Risk 
factors for prosthetic hip and knee infections according to arthroplasty 
site. J Hosp Infect. 2011;79:129–33.
 42. Berbari EF, Osmon DR, Lahr B, Eckel‑Passow JE, Tsaras G, Hanssen AD, 
et al. The mayo prosthetic joint infection risk score: implication for surgi‑
cal site infection reporting and risk stratification. Infect Control Hosp 
Epidemiol. 2012;33:774–81.
 43. Mraovic B, Suh D, Jacovides C, Parvizi J. Perioperative hyperglycemia 
and postoperative infection after lower limb arthroplasty. J Diabetes Sci 
Technol. 2011;5:412–8.
 44. Jämsen E. Risk factors for infection after knee arthroplasty. J Bone Joint 
Surg Am. 2009;91:38.
 45. Bongartz T, Halligan CS, Osmon DR, Reinalda MS, Bamlet WR, Crowson 
CS, et al. Incidence and risk factors of prosthetic joint infection after 
total hip or knee replacement in patients with rheumatoid arthritis. 
Arthritis Rheum. 2008;59:1713–20.
 46. Portillo ME, Salvadó M, Alier A, Sorli L, Martínez S, Horcajada JP, et al. 
Prosthesis failure within 2 years of implantation is highly predictive of 
infection. Clin Orthop Relat Res. 2013;471:3672–8.
 47. Lachiewicz PF, Rogers GD, Thomason HC. Aspiration of the hip joint 
before revision total hip arthroplasty. Clinical and laboratory factors 
influencing attainment of a positive culture. J Bone Joint Surg Am. 
1996;78:749–54.
 48. Carroll K, Dowsey M, Choong P, Peel T. Risk factors for superficial wound 
complications in hip and knee arthroplasty. Clin Microbiol Infect. 
2014;20:130–5.
 49. Wymenga AB, van Horn JR, Theeuwes A, Muytjens HL, Slooff TJ. 
Perioperative factors associated with septic arthritis after arthroplasty. 
Prospective multicenter study of 362 knee and 2651 hip operations. 
Acta Orthop Scand. 1992;63:665–71.
 50. Sousa R, Muñoz‑Mahamud E, Quayle J, Dias da Costa L, Casals C, Scott P, 
et al. Is asymptomatic bacteriuria a risk factor for prosthetic joint infec‑
tion? Clin Infect Dis. 2014;59:41–7 (Oxford University Press).
 51. Murdoch DR, Roberts SA, Fowler VG Jr, Shah MA, Taylor SL, Morris AJ, 
et al. Infection of orthopedic prostheses after Staphylococcus aureus 
bacteremia. Clin Infect Dis. 2001;32:647–9.
 52. Coelho‑Prabhu N, Oxentenko AS, Osmon DR, Baron TH, Hanssen AD, 
Wilson WR, et al. Increased risk of prosthetic joint infection associated 
with esophago‑gastro‑duodenoscopy with biopsy. SORT. 2013;84:82–6.
 53. Mishriki SF, Law D, Jeffery PJ. Factors affecting the incidence of postop‑
erative wound infection. J Hosp Infect. 1990;16:223–30.
 54. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. 
Surviving sepsis campaign: international guidelines for management of 
severe sepsis and septic shock: 2014. Crit Care Med. 2012;2013:580–637.
 55. Llewelyn M, Cohen J. International sepsis forum. Diagnosis of infection 
in sepsis. Intensive Care Med. 2001;27:S10–32.
 56. Reinhart K, Brunkhorst FM, Bone HG, Bardutzky J, Dempfle CE, Kern W, 
et al. Prävention, diagnose, therapie und Nachsorge der Sepsis. Der 
Anaesthesist. 2010;59:1–68.
 57. Brook I, Frazier EH. Aerobic and anaerobic microbiology of retroperito‑
neal abscesses. Clin Infect Dis. 1998;26:938–41.
 58. Nichols RL, Smith JW. Wound and intraabdominal infections: micro‑
biological considerations and approaches to treatment. Clin Infect Dis. 
1993;16(Suppl 4):S266–72.
 59. Bates DW, Cook EF, Goldman L, Lee TH. Predicting bacteremia in 
hospitalized patients. A prospectively validated model. Ann Intern Med. 
1990;113:495–500.
 60. Smith‑Elekes S, Weinstein MP. Blood cultures. Infect Dis Clin North Am. 
1993;7:221–34.
 61. Koperna T, Schulz F. Relaparotomy in peritonitis: prognosis and treat‑
ment of patients with persisting intraabdominal infection. World J Surg. 
2000;24:32–7.
 62. Sia IG, Berbari EF, Karchmer AW. Prosthetic joint infections. Infect Dis 
Clin North Am. 2005;19:885–914.
 63. Teller RE, Christie MJ, Martin W, Nance EP, Haas DW. Sequential indium‑
labeled leukocyte and bone scans to diagnose prosthetic joint infec‑
tion. Clin Orthop Relat Res. 2000;373:241–7.
 64. Bottner F, Wegner A, Winkelmann W, Becker K, Erren M, Götze C. 
Interleukin‑6, procalcitonin and TNF‑alpha: markers of peri‑prosthetic 
infection following total joint replacement. J Bone Joint Surg Br. 
2007;89:94–9.
 65. Valle Della CJ, Sporer SM, Jacobs JJ, Berger RA, Rosenberg AG, Paprosky 
WG. Preoperative testing for sepsis before revision total knee arthro‑
plasty. J Arthroplast. 2007;22:90–3.
 66. Greidanus NV, Masri BA, Garbuz DS, Wilson SD, McAlinden MG, Xu M, 
et al. Use of erythrocyte sedimentation rate and C‑reactive protein level 
to diagnose infection before revision total knee arthroplasty. A prospec‑
tive evaluation. J Bone Joint Surg Am. 2007;89:1409–16.
 67. Kamme C, Lindberg L. Aerobic and anaerobic bacteria in deep 
infections after total hip arthroplasty: differential diagnosis between 
infectious and non‑infectious loosening. Clin Orthop Relat Res. 
1981;154:201–7.
 68. Schinsky MF. Perioperative testing for joint infection in patients under‑
going revision total hip arthroplasty. J Bone Joint Surg Am. 2008;90:1869.
 69. Savarino L, Baldini N, Tarabusi C, Pellacani A, Giunti A. Diagnosis of infec‑
tion after total hip replacement. J Biomed Mater Res. 2004;70:139–45.
 70. Fink B, Makowiak C, Fuerst M, Berger I, Schäfer P, Frommelt L. The value 
of synovial biopsy, joint aspiration and C‑reactive protein in the diagno‑
sis of late peri‑prosthetic infection of total knee replacements. J Bone 
Joint Surg Br. 2008;90:874–8.
 71. Di Cesare PE, Chang E, Preston CF, Liu C‑J. Serum interleukin‑6 as a 
marker of periprosthetic infection following total hip and knee arthro‑
plasty. J Bone Joint Surg Am. 2005;87:1921–7.
 72. Wirtz DC, Heller KD, Miltner O, Zilkens KW, Wolff JM. Interleukin‑6: a 
potential inflammatory marker after total joint replacement. Int Orthop 
SICO. 2000;24:194–6.
Page 15 of 15Mühlhofer et al. Eur J Med Res  (2017) 22:8 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 73. Worthington T, Dunlop D, Casey A. Serum procalcitonin, interleukin‑6, 
soluble intercellular adhesin molecule‑1 and IgG to shortchain exocel‑
lular lipoteichoic acid as predictors of infection in total joint prosthesis 
revision. Br J Biomed Sci. 2010;67:71–6.
 74. Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, 
et al. Executive summary: diagnosis and management of prosthetic 
joint infection: clinical practice guidelines by the infectious diseases 
society of America. Clin Infect Dis. 2012;56:1–10.
 75. Bogut A, Niedźwiadek J, Kozioł‑Montewka M, Strzelec‑Nowak D, Blacha 
J, Mazurkiewicz T, et al. Sonication as a diagnostic approach used to 
investigate the infectious etiology of prosthetic hip joint loosening. Pol 
J Microbiol. 2014;63:299–306.
 76. Trampuz A, Piper KE, Jacobson MJ, Hanssen AD, Unni KK, Osmon DR, 
et al. Sonication of removed hip and knee prostheses for diagnosis of 
infection. N Engl J Med. 2007;357:654–63.
 77. Trampuz A, Hanssen AD, Osmon DR, Mandrekar J, Steckelberg JM, Patel 
R. Synovial fluid leukocyte count and differential for the diagnosis of 
prosthetic knee infection. AJM. 2004;117:556–62.
 78. Mulcahy DM, Fenelon GC, McInerney DP. Aspiration arthrography of the 
hip joint. Its uses and limitations in revision hip surgery. J Arthroplast. 
1996;11:64–8.
 79. Malhotra R, Morgan D. Role of core biopsy in diagnosing infection 
before revision hip arthroplasty. J Arthroplast. 2004;19:78–87.
 80. Barrack RL, Jennings RW, Wolfe MW, Bertot AJ. The coventry award. The 
value of preoperative aspiration before total knee revision. Clin Orthop 
Relat Res. 1997;345:8–16.
 81. Williams JL, Norman P, Stockley I. The value of hip aspiration versus 
tissue biopsy in diagnosing infection before exchange hip arthroplasty 
surgery. J Arthroplast. 2004;19:582–6.
 82. Dinneen A, Guyot A, Clements J. Synovial fluid white cell and differ‑
ential count in the diagnosis or exclusion of prosthetic joint infection. 
Bone Joint J. 2013;95:554–7.
 83. Jacovides CL, Parvizi J, Adeli B, Am Jung K. Molecular markers for diag‑
nosis of periprosthetic joint infection. J Arthroplast. 2011;26:99–103.
 84. Parvizi J, McKenzie JC, Cashman JP. Diagnosis of periprosthetic joint 
infection using synovial C‑reactive protein. J Arthroplast. 2012;27:12–6.
 85. Deirmengian C, Kardos K, Kilmartin P, Cameron A, Schiller K, Parvizi J. 
Combined measurement of synovial fluid‑defensin and C‑reactive pro‑
tein levels: highly accurate for diagnosing periprosthetic joint infection. 
J Bone Joint Surg Am. 2014;96:1439–45.
 86. Francés Borrego A, Martínez FM, Cebrian Parra JL, Grañeda DS, Crespo 
RG, López‑Durán Stern L. Diagnosis of infection in hip and knee revi‑
sion surgery: intraoperative frozen section analysis. Int Orthop SICO. 
2006;31:33–7.
 87. Nuñez LV, Buttaro MA, Morandi A, Pusso R, Piccaluga F. Frozen sections 
of samples taken intraoperatively for diagnosis of infection in revision 
hip surgery. SORT. 2007;78:226–30.
 88. Banit DM, Kaufer H, Hartford JM. Intraoperative frozen section 
analysis in revision total joint arthroplasty. Clin Orthop Relat Res. 
2002;401:230–8.
 89. Fink B, Gebhard A, Fuerst M, Berger I, Schäfer P. High diagnostic value of 
synovial biopsy in periprosthetic joint infection of the hip. Clin Orthop 
Relat Res. 2013;471:956–64.
 90. Fink B, Gebhard A, Fuerst M, Berger I, Schäfer P. High diagnostic value of 
synovial biopsy in periprosthetic joint infection of the hip. Clin Orthop 
Relat Res. 2012;471:956–64.
 91. Atkins BL, Athanasou N, Deeks JJ, Crook DW, Simpson H, Peto TE, et al. 
Prospective evaluation of criteria for microbiological diagnosis of 
prosthetic‑joint infection at revision arthroplasty. The OSIRIS Collabora‑
tive Study Group. J Clin Microbiol. 1998;36:2932–9.
 92. Marin M, Garcia‑Lechuz JM, Alonso P, Villanueva M, Alcala L, Gimeno M, 
et al. Role of universal 16S rRNA gene PCR and sequencing in diagnosis 
of prosthetic Joint Infection. J Clin Microbiol. 2012;50:583–9.
 93. Della Valle C, Parvizi J, Bauer TW, Dicesare PE, Evans RP, Segreti J, 
Spangehl M, Watters WC, III, Keith M, Turkelson CM, Wies JL, Sluka P, 
Hitchcock K. Diagnosis of periprosthetic joint infections of the hip and 
knee. J Am Acad Orthop Surg. 2010;18:760–70.
 94. Berbari E, Mabry T, Tsaras G, Spangehl M, Erwin PJ, Murad MH, et al. 
Inflammatory blood laboratory levels as markers of prosthetic joint 
infection: a systematic review and meta‑analysis. J Bone Joint Surg. 
2010;92:2102–9.
 95. Murray RP, Bourne MH, Fitzgerald RH. Metachronous infections in 
patients who have had more than one total joint arthroplasty. J Bone 
Joint Surg Am. 1991;73:1469–74.
 96. Barrack RL, Harris WH. The value of aspiration of the hip joint before 
revision total hip arthroplasty. J Bone Joint Surg Am. 1993;75:66–76.
 97. Yee DKH, Chiu KY, Yan CH, Ng FY. Review article: joint aspiration for 
diagnosis of periprosthetic infection. J Orthop Surg (Hong Kong). 
2013;21:236–40.
 98. Detection of occult infection following total joint arthroplasty using 
sequential technetium‑99 m HDP bone scintigraphy and indium‑111 
WBC imaging. 1988;29:1347–53. http://eutils.ncbi.nlm.nih.gov/entrez/
eutils/elink.fcgi?dbfrom=pubmed&id=3404252&retmode=ref&cmd=
prlinks.
 99. Spangehl MJ, Masri BA, O’connell JX, Duncan CP. Prospective analysis 
of preoperative and intraoperative investigations for the diagnosis of 
infection at the sites of two hundred and two revision total hip arthro‑
plasties. J Bone Joint Surg Am. 1999;81(5):672–83.
 100. Ghanem E, Parvizi J, Burnett RSJ, Sharkey PF, Keshavarzi N, Aggarwal 
A, et al. Cell count and differential of aspirated fluid in the diagnosis 
of infection at the site of total knee arthroplasty. J Bone Joint Surg. 
2008;90:1637–43.
 101. Zmistowski B, Restrepo C, Huang R, Hozack WJ, Parvizi J. Periprosthetic 
joint infection diagnosis. J Arthroplast. 2012;27:1589–93.
 102. Minassian AM, Newnham R, Kalimeris E, Bejon P, Atkins BL, Bowler IC. 
Use of an automated blood culture system (BD BACTEC™) for diagnosis 
of prosthetic joint infections: easy and fast. BMC Infect Dis. 2014;14:1–7.
 103. Is “aseptic” loosening of the prosthetic cup after total hip replacement 
due to nonculturable bacterial pathogens in patients with low‑grade 
infection? Oxford University Press; 2004;39:1599–603. http://cid.oxford‑
journals.org/lookup/doi/10.1086/425303.
 104. Schäfer P, Fink B, Sandow D, Margull A, Berger I, Frommelt L. Prolonged 
bacterial culture to identify late periprosthetic joint infection: a promis‑
ing strategy. Clin Infect Dis. 2008;47:1403–9 (Oxford University 
Press).
 105. Saleh KJ, Clark CR, Sharkey PF, Goldberg VM, Rand JA, Brown GA. 
Modes of failure and preoperative evaluation. J Bone Joint Surg Am. 
2003;85(Suppl 1):S21–5.
 106. Diagnosis of periprosthetic joint infection: the utility of a simple yet 
unappreciated enzyme. Am Orthop Assoc; 2011;93:2242–8. http://jbjs.
org/cgi/doi/10.2106/JBJS.J.01413.
 107. Clarke MT, Arora A, Villar RN. Hip arthroscopy: complications in 1054 
cases. Clin Orthop Relat Res. 2003;406:84–8.
